FDA approves Astellas’ VYLOY for gastric cancer treatment
Astellas Pharma has received approval from the FDA for VYLOY in conjunction with...
FDA clamps partial hold on Phase III trial of BioNTech ...
A partial hold was placed on the trial after results showed variance between squ...
FibroBiologics and Charles River link for chronic disea...
FibroBiologics has entered a master services agreement with Charles River Labora...